With 1.5 million shares bought on Dec 26 at $1.37 each, abrdn has raised its stake in AEM Holdings to 6.032%.
AEM Holdings' second and third largest shareholders have been actively trading their holdings over the past month.
UK-based asset manager abrdn bought shares of the SGX-listed chip-tester at a slightly higher level versus what it sold for just days earlier.
On Nov 26, abrdn sold 514,000 shares at around $1.33 each. On Dec 19, abrdn sold another 1.77 million shares at around $1.32 each.
Yet, on Dec 26, abrdn paid $2.5 million to buy 1.5 million shares, which works out to an average of $1.37 each. This brings abrdn's total stake in AEM to nearly 18.9 million shares, or 6.032%, up from 5.553%.
On Dec 16, Malaysia's Employees Provident Fund paid $1.36 each for one million shares. On Dec 20, EPF, known to be a relatively active trader of shares, sold 265,000 shares for around $1.3 each.
Most recently, on Dec 23, it paid around $1.33 each for nearly 1.9 million shares, bringing its total stake to around 26.8 million shares, equivalent to 8.545%, up from 7.939%.
On Nov 12, AEM reported a net loss of $917,000 for its 3QFY2024 ended Sept, down from $1.5 million recorded in the year-earlier three months to Sept 2023. This brings its 9MFY2024 net loss to $95,000. Revenue for its 3QFY2024 was $74.2 million, down 6.5%.
Temasek Holdings, via a vehicle called Venezio Investments, is AEM's single largest shareholder with a stake that has been held steady at 12.5%.
AEM hares closed at $1.38 on Dec 27, up 0.73% for the day but down 60% year to date.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.